CRYM (crystallin mu) is a multifunctional protein with distinct metabolic and endocrine roles. Enzymatically, CRYM catalyzes NAD(P)H-dependent reduction of cyclic ketimine substrates, particularly delta(1)-piperideine-2-carboxylate and delta(1)-pyrroline-2-carboxylate, positioning it centrally in lysine and glutamate metabolism 1. Beyond its enzymatic function, CRYM serves as a high-affinity intracellular thyroid hormone (T3/T4) binding protein that buffers freely available T3 in the cytosol, thereby modulating thyroid hormone signaling 23. In the central nervous system, CRYM-expressing striatal astrocytes gate perseverative behavior through control of presynaptic neurotransmitter release, with loss of CRYM increasing perseveration and synaptic excitation imbalance 4. CRYM mutations cause autosomal dominant deafness (DFNA40), with aberrant protein localization disrupting inner ear potassium-ion recycling 5. Clinically, reduced CRYM expression associates with Alzheimer's disease pathology and potential early diagnostic value 6, while low CRYM in prostate cancer correlates with biochemical recurrence and poor prognosis through loss of antagonism against T3- and androgen signaling 7. Downregulation of CRYM expression characterizes typical Duchenne muscular dystrophy muscle pathology 8. These findings establish CRYM as a critical metabolic regulator with implications across neurological, endocrine, and cancer biology.